1Diabetes control and complications Trial Research Group. The effect in intensive treatment of diabetes on the development and progression of long-time complications in insulin-dependent diabetes mellitus[J]. N Engl J Med, 1993,239:977
1E. Torlone,C. Fanelli,A. M. Rambotti,G. Kassi,F. Modarelli,A. Vincenzo,L. Epifano,M. Ciofetta,S. Pampanelli,P. Brunetti,G. B. Bolli. Pharmacokinetics, pharmacodynamics and glucose counterregulation following subcutaneous injection of the monomeric insulin analogue [Lys(B28),Pro(B29)] in IDDM[J] 1994,Diabetologia(7):713～720
2Gerstein HC,Miller Me,Byington RP,et al.Effects of intensive glucose lowering in type 2 diabetes[J].Nengl J Med,2008,358(24):2 545-2 559.
3Homan RR,Paul SK,Bethel MA,et al.10-year follow-up of intensive glucose control intype 2 diabetes[J].Nengl J Med,2008,359(15):1 577-1 589.
4Lee SW,Sweeney T,Clausen D,et al.Combined insulin pump therapy with real-time continuous glucose monitoring significantly improves glycemic control compared to multiple daily injection therapy in pump nave patients with type 1 diabetes;single center pilot study experience[J].J Diabetes Sci Technol,2007,1(3):400-404.
5Gerstein HC,Miller Me,Byington RP,等.Effects of intensive glucose lowering in type 2 diabetes[J].Nengl J Med,2008,358 (24):2545- 2559.
6UK Prospective Diabetes Study (UKPDS) Group.Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)[J].Lancet,1998,352(9131):837-853.
